Skip to search formSkip to main contentSkip to account menu

Dermatitis acneiform

Known as: ACNEIFORM DERMATITIS, Rash acneiform 
Cutaneous eruptions resembling acne, characterized by the presence of papulonodules, pustules, comedones, or cysts in the face, trunk, and… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

AcneAcne Vulgaris
Integumentary systemSkin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD…
Highly Cited
2015
Highly Cited
2015
Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal…
103 Background: BRAF V600E mutations occur in 5–10% of mCRC and confer a poor prognosis. Unlike BRAFm melanoma, BRAF and MEK… 
2015
2015
A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer.
Highly Cited
2015
Highly Cited
2015
First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the…
Highly Cited
2013
Highly Cited
2013
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
Highly Cited
2010
Highly Cited
2010
The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer
Purpose: In part A, the aim was to define the maximum tolerated dose (MTD) of the hydrogen sulfate (Hyd-Sulfate) oral capsule… 
Highly Cited
2009
Highly Cited
2009
Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients
Mammalian target of rapamycin (mTOR) inhibitors may have efficacy as an intervention for advanced malignancies. Oral ulceration… 
Highly Cited
2008
Highly Cited
2008
Rosacea treatment using the new‐generation, high‐energy, 595 nm, long pulse‐duration pulsed‐dye laser
Rosacea results from sun‐induced hyper‐vascularity of exposed facial skin, often accompanied by acneiform papules and pustules… 
Review
2006
Review
2006
Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis
All types of leukaemia can disseminate to the skin, producing cutaneous deposits known as leukaemia cutis (LC). We undertook a… 
Review
2001
Review
2001
Retinoids – Which Dermatological Indications Will Benefit in the Near Future?
Retinoids are compounds with pleiotropic functions and a relatively selective targeting of certain skin structures. They are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)